Idacta-mab INT-001 represents the promising medicinal method for combating selected hematologic cancers. The immunoglobulin is a special mechanism of action, particularly binding to CD-38, the cell-surface molecule https://socialrus.com/story24449061/idacta-mab-int-001-the-novel-antibody-in-progression